Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fogelman

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Lipid Research|June 9, 2017
Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunumPallavi Mukherjee, Greg Hough, Arnab Chattopadhyay, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapyRobert L Fine, Samir S Shah, Thomas A Moulton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic CancerSeyed Pairawan, Kenneth R Hess, Filip Janku, et al.
Drug Design, Development and Therapy|September 15, 2015
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analoguesEdward M Wolin, Barbara Jarzab, Barbro Eriksson, et al.
Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Plos One|March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2017
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal CancerChristine M Parseghian, Nila U Parikh, Ji Yuan Wu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2018
Physical activity and exercise during preoperative pancreatic cancer treatmentNathan H Parker, An Ngo-Huang, Rebecca E Lee, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Cancer Discovery|July 18, 2022
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic CancerAislyn Schalck, Donastas Sakellariou-Thompson, Marie-Andrée Forget, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Lipid Research|June 9, 2017
Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunumPallavi Mukherjee, Greg Hough, Arnab Chattopadhyay, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapyRobert L Fine, Samir S Shah, Thomas A Moulton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic CancerSeyed Pairawan, Kenneth R Hess, Filip Janku, et al.
Drug Design, Development and Therapy|September 15, 2015
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analoguesEdward M Wolin, Barbara Jarzab, Barbro Eriksson, et al.
Oncotarget|November 21, 2017
Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experienceJennifer B Goldstein, Chad Tang, Kenneth R Hess, et al.
Plos One|March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2017
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal CancerChristine M Parseghian, Nila U Parikh, Ji Yuan Wu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2018
Physical activity and exercise during preoperative pancreatic cancer treatmentNathan H Parker, An Ngo-Huang, Rebecca E Lee, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Cancer Discovery|July 18, 2022
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic CancerAislyn Schalck, Donastas Sakellariou-Thompson, Marie-Andrée Forget, et al.
Pageof 6